ADMA vs. BMY
Compare and contrast key facts about ADMA Biologics, Inc. (ADMA) and Bristol-Myers Squibb Company (BMY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ADMA or BMY.
Correlation
The correlation between ADMA and BMY is 0.09, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ADMA vs. BMY - Performance Comparison
Key characteristics
ADMA:
4.97
BMY:
0.64
ADMA:
5.30
BMY:
1.21
ADMA:
1.72
BMY:
1.15
ADMA:
4.86
BMY:
0.38
ADMA:
39.90
BMY:
1.57
ADMA:
8.16%
BMY:
11.56%
ADMA:
65.42%
BMY:
28.50%
ADMA:
-91.28%
BMY:
-70.62%
ADMA:
-23.08%
BMY:
-23.12%
Fundamentals
ADMA:
$4.40B
BMY:
$116.92B
ADMA:
$0.27
BMY:
-$3.58
ADMA:
0.00
BMY:
1.92
ADMA:
$382.81M
BMY:
$47.44B
ADMA:
$186.78M
BMY:
$33.40B
ADMA:
$98.48M
BMY:
$5.06B
Returns By Period
In the year-to-date period, ADMA achieves a 284.96% return, which is significantly higher than BMY's 17.38% return. Over the past 10 years, ADMA has outperformed BMY with an annualized return of 4.61%, while BMY has yielded a comparatively lower 2.84% annualized return.
ADMA
284.96%
-18.58%
58.18%
321.31%
32.75%
4.61%
BMY
17.38%
-0.95%
40.36%
17.50%
1.50%
2.84%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ADMA vs. BMY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for ADMA Biologics, Inc. (ADMA) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ADMA vs. BMY - Dividend Comparison
ADMA has not paid dividends to shareholders, while BMY's dividend yield for the trailing twelve months is around 4.19%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ADMA ADMA Biologics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
BMY Bristol-Myers Squibb Company | 4.19% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% | 2.46% | 3.31% |
Drawdowns
ADMA vs. BMY - Drawdown Comparison
The maximum ADMA drawdown since its inception was -91.28%, which is greater than BMY's maximum drawdown of -70.62%. Use the drawdown chart below to compare losses from any high point for ADMA and BMY. For additional features, visit the drawdowns tool.
Volatility
ADMA vs. BMY - Volatility Comparison
ADMA Biologics, Inc. (ADMA) has a higher volatility of 13.24% compared to Bristol-Myers Squibb Company (BMY) at 6.16%. This indicates that ADMA's price experiences larger fluctuations and is considered to be riskier than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ADMA vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between ADMA Biologics, Inc. and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities